Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 4,051–4,075 of 27,380 studies, newest first · page 163 of 1096.
June 2025 25
-
2025-06-09
Genetic background and multidomain interventions in mild cognitive impairment
40/100 ✓ Peer-reviewed Prevention trials Alzheimer s Research & Therapy
Key finding: Although the partial efficacy of multidomain interventions for dementia prevention has been demonstrated, understanding the characteristics of individuals who benefit most from these interventions is crucial for optimizing resource allocation. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Comprehensive Anatomical Staging Predicts Clinical Progression in Mild Cognitive Impairment: A Data-Driven Approach
41/100 ✓ Peer-reviewed Mild cognitive impairment International Journal of Molecular Sciences
Key finding: Alzheimer’s disease (AD) presents significant challenges in clinical practice due to its heterogeneous manifestation and variable progression rates. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Evaluating EEG complexity and spectral signatures in Alzheimer’s disease and frontotemporal dementia: evidence for rostrocaudal asymmetry
39/100 ✓ Peer-reviewed Lewy body dementia npj Aging
Key finding: In contrast, fractal dimension and long-range temporal correlations (LRTCs) revealed distinct topographical differences: AD exhibited rostral dominance in fractal dimension, whereas FTD showed caudal dominance. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Regional Differences in Dementia Incidence Among US Veterans
54/100 ✓ Peer-reviewed How common it is JAMA Neurology
Key finding: Among the 1 268 599 participants (mean age, 73.9 [SD, 6.1] years; n = 25 335 [2%] female), dementia incidence rates per 1000 person-years were lowest in the Mid-Atlantic (11.2; 95% CI, 11.1-11.4) and highest in the Southeast (14.0; 95% CI, 13.8-14.2). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Dementia in Sub-Saharan Africa: Risk factors, public perception, and management approaches
41/100 ✓ Peer-reviewed Prevention and risk Journal of Medicine Surgery and Public Health
Key finding: Incidence figures are also weak and mostly restricted to a few countries, thus potentially underestimating the true regional burden. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Brain tau PET-based identification and characterization of subpopulations in patients with Alzheimer’s disease using deep learning-derived saliency maps
44/100 ✓ Peer-reviewed Genetics EJNMMI Physics
Key finding: Alzheimer’s disease (AD) is a heterogeneous neurodegenerative disorder in which tau neurofibrillary tangles are a pathological hallmark closely associated with cognitive dysfunction and neurodegeneration. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Active Travel Mode and Incident Dementia and Brain Structure
57/100 ✓ Peer-reviewed Genetics JAMA Network Open
Key finding: The study encompassed 479 723 participants (mean [SD] age, 56.5 [8.1] years; 260 730 females [54.4%]), including 271 690 in the YOD analyses and 334 939 in the LOD analyses. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Prediction Of Alzheimer Patients with Machine Learning Algorithms
28/100 ✓ Peer-reviewed Genetics Indonesian Journal of Computer Science
Key finding: The results indicate that the Random Forest algorithm with Transformer methods achieved the highest accuracy of 98.9%. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2025-06-09
White Matter Abnormalities and Cognition in Aging and Alzheimer Disease
70/100 ✓ Peer-reviewed Genetics JAMA Neurology
Key finding: Of 4467 participants who underwent 9208 longitudinal cognitive sessions, 2698 (60.4%) were female, and the mean age (SD) was 74.3 (9.2) years; 3213 were cognitively unimpaired, 972 had mild cognitive impairment, and 282 had AD dementia. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Antiamyloid treatment for dementia: concerns outweigh hopes
35/100 ✓ Peer-reviewed Drug development Current opinion in psychiatry
Key finding: Recent findings There is an association, but Alzheimer pathology explains less than 40% of the attributable risk of dementia when other pathologies such as vascular, Lewy Body and TDP-43 are accounted. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-09
Estimation of the value-based price of a blood test for Alzheimer's disease pathology in primary and specialty care in the U.S
45/100 ✓ Peer-reviewed Costs and economics Journal of Prevention of Alzheimer's Disease
Key finding: The results project substantial cost savings from implementing a blood test for AD pathology within the diagnostic pathway based on modeling results, which future research should confirm with actual data. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-08
Metformin protects against insulin resistance-related dementia risk involving restored microglial homeostasis
39/100 ✓ Peer-reviewed Inflammation and the immune system Life sciences
Key finding: Our findings suggest that metformin exerts therapeutic effects beyond glycemic control in the context of T2D. By mitigating neuroinflammation and modulating microglial autophagy, metformin emerges as a promising therapeutic agent for cognitive decline associated with diabetes and potentially other neurological disorders. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-08
A rapid scoping review on operationalizing cognitive and social activities in research on dementia risk reduction
37/100 ✓ Peer-reviewed Prevention trials Aging & Mental Health
Key finding: Across 58 studies, 38 had an observational design and predominantly used questionnaires to measure cognitive and social activities. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-07
Ciliatoside A attenuates neuroinflammation in Alzheimer's disease by activating mitophagy and inhibiting NLRP3 inflammasome activation
43/100 ✓ Peer-reviewed Inflammation and the immune system Phytomedicine : international journal of phytotherapy and phytopharmacology
Key finding: Our results demonstrate CA effectively inhibits NLRP3 inflammasome activation, reduces microglial pyroptosis, and mitigates oxidative stress-induced mitochondrial impairment in BV-2 cells. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-07
Plasma biomarkers for early detection of alzheimer's disease: a cross-sectional study in a Japanese cohort
54/100 ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy
Key finding: Sixty-nine HC, 13 preclinical AD, 38 AD-MCI, 44 AD-D, and 79 non-AD CI participants were included. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-07
The continuous learning needs of personal support workers who care for people living with dementia in long-term care
37/100 ✓ Peer-reviewed Clinical safety Educational Gerontology
Key finding: Personal support workers (PSWs) in long-term care (LTC) homes provide the most care to people living with dementia, yet receive the least education compared to other healthcare professionals.
Full summary, score breakdown and related studies → Original source
-
2025-06-07
Impact of Glucagon‐Like Peptide‐1 Receptor Agonists on the Dementia Incidence in Patients With Type 2 Diabetes Mellitus: A Population‐Based Longitudinal Cohort Study
47/100 ✓ Peer-reviewed How common it is Diabetes/Metabolism Research and Reviews
Key finding: Among a cohort comprising 109,778 individuals, the use of GLP-1RA demonstrated a reduced risk of dementia compared with its non-use (aHR, 0.90; 95% CI, 0.83-0.97). +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-07
Ambulatory Care Sensitive Hospitalizations and Disparities Among Older Adults With Dementia Before and During the Pandemic
38/100 ✓ Peer-reviewed Disparities Journal of the American Geriatrics Society
Key finding: The study included 2.35 million beneficiaries in 2019 and 1.85 million in 2021. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-07
Bridging the gap: A conversion framework for CDR-SB and MoCA scores in Alzheimer's disease and related dementia
49/100 ✓ Peer-reviewed Getting a diagnosis The Journal of Prevention of Alzheimer s Disease
Key finding: CDR-SB and MoCA scores showed strong inverse correlation (Spearman's ρ = -0.68; p < 0.001). +2 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-06
Microglia-derived extracellular vesicles mediate fine particulate matter-induced Alzheimer's disease-like behaviors through the miR-34a-5p/DUSP10/p-p38 MAPK pathway
43/100 ✓ Peer-reviewed Risk factors Journal of hazardous materials
Key finding: Fine particulate matter (PM2.5), a major component of air pollution, poses significant global health risks. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-06
Plasma and MRI biomarkers capture neuronal damage in former professional boxers
66/100 ✓ Peer-reviewed Biomarkers Scientific reports
Key finding: We evaluated blood-based biomarkers for neurodegeneration and Alzheimer's Disease (AD) pathology, clinical features, and MRI biomarkers in former professional boxers compared to patients with AD or patients with subjective cognitive decline (SCD). +2 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-06
Communicating palliative hope in late-stage dementia: thematic analysis of hope work in care plan meetings with nursing home residents’ families
37/100 ✓ Peer-reviewed Brain tissue and pathology The Journals of Gerontology Series B
Key finding: We identified three main themes of palliative hope in late-stage dementia: 1) Life is good and there is still time, 2) Agency and identity are not lost, and 3) Death will be good and professional support is available. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-06
The patient pathway for mild cognitive impairment due to Alzheimer’s disease in Asia: Current practices, barriers, and expert recommendations for optimization
42/100 ✓ Peer-reviewed Mild cognitive impairment The Journal of Prevention of Alzheimer s Disease
Key finding: Forty-four physicians, primarily neurologists (n = 31; 70.5 %), were interviewed. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-06
Readability of AI-Generated Patient Information Leaflets on Alzheimer’s, Vascular Dementia, and Delirium
41/100 ✓ Peer-reviewed Lewy body dementia Cureus
Key finding: There are meaningful differences in the readability of patient information generated by different large language models. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-06
Training for dementia care and support in rural and remote Australia: appraisals from a nationwide workforce survey
41/100 ✓ Peer-reviewed Disparities BMC Geriatrics
Key finding: There were 558 respondents from residential aged care, community/primary care and hospital settings across all Australian states and territories. +4 more findings
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →